Concepedia

Author

Jeanne M. Lusher

Children's Hospital of Michigan

Also Known As

Darintr Sosothikul, J Lusher, J M Lusher, J. LUSHER, J. Lusher, J. M. LUSHER, J. M. Lusher, J.M. LUSHER, J.M. Lusher, JEANNE LUSHER

260

Publications

9.8K

Citations

54

H-Index

131

Concepts

All Affiliations

Children's Hospital of MichiganWayne State UniversityMedical College of WisconsinVersiti Blood Center of WisconsinIndiana Hemophilia and Thrombosis Center
JM

About

Jeanne M. Lusher is an author at Children's Hospital of Michigan specializing in medicine, hematology, and thrombosis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

35

56

3.4K

2

Health Sciences

9

9

1.1K

3

Natural Sciences

2

2

57

4

Education

1

1

182

5

Engineering

1

1

25

Jeanne M. Lusher

×

102

Publications

7.9K

Citations

47

H-Index

YearCitations

Definitions in Hemophilia

Frits R. Rosendaal, Louis M. Aledort, Jeanne M. Lusher,

Thrombosis and Haemostasis

2001

757

Recombinant Factor VIII for the Treatment of Previously Untreated Patients with Hemophilia A -- Safety, Efficacy, and Development of Inhibitors

Jeanne M. Lusher, Steven Arkin, Charles F. Abildgaard,

New England Journal of Medicine

1993

493

Home Treatment of Mild to Moderate Bleeding Episodes Using Recombinant Factor VIIa (Novoseven) in Haemophiliacs with Inhibitors

Louis M. Aledort, Diana S. Beardsley, Herbert Cooper,

Thrombosis and Haemostasis

1998

355

Predeposited Autologous Blood for Elective Surgery

Pearl T.G.V. Toy, Ronald G. Strauss, Linda C. Stehling,

New England Journal of Medicine

1987

293

Human Recombinant DNA–Derived Antihemophilic Factor (Factor VIII) in the Treatment of Hemophilia A

Richard S. Schwartz, Charles F. Abildgaard, Louis M. Aledort,

New England Journal of Medicine

1990

263

Efficacy of Prothrombin-Complex Concentrates in Hemophiliacs with Antibodies to Factor VIII

Jeanne M. Lusher, Sandor S. Shapiro, Joseph E. Palascak,

New England Journal of Medicine

1980

254

Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion

Jerry S. Powell, Margaret V. Ragni, Gilbert White,

Blood

2003

219

Factor IX Inhibitors and Anaphylaxis in Hemophilia B

Indira Warrier, Bruce M. Ewenstein, Marion A. Koerper,

˜The œAmerican journal of pediatric hematology/oncology

1997

183

Recombinant Factor VIII for the Treatment of Previously Untreated Patients with Hemophilia A

Jeanne M. Lusher, Steven Arkin, C. F. ABILGAARD,

Survey of Anesthesiology

1993

182

Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor

Veronica H. Flood, Joan Cox Gill, Patricia A. Morateck,

Blood

2010

180

Page 1